Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Clinical trial NCT02066181 · COMPLETED
Trial details
- NCT number
- NCT02066181
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-21
- Primary completion
- 2019-07-03
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.